Histidine-rich glycoprotein binding to activated human platelets

Area of Science:

• Hematology
• Biochemistry

Background:

• Histidine-rich glycoprotein (HRGP) is a plasma protein with poorly understood interactions with blood cells.
• Platelets play a crucial role in hemostasis and thrombosis, and their activation involves complex molecular events.

Purpose of the Study:

• To investigate the specific binding of purified HRGP to human platelets.
• To determine the factors influencing HRGP-platelet interactions, including platelet activators, divalent cations, and inhibitors.

Main Methods:

• Human platelets were activated using bisdiazoniumbenzidine-crosslinked immunoglobulin G (BDB-IgG), thrombin, or collagen.
• Radiolabeled 125I-HRGP was used to quantify binding to activated platelets.
• The effects of divalent cations and platelet inhibitors (acetylsalicylic acid, prostaglandin E1, cytochalasin B) on binding were assessed.
• Kinetic experiments involving enzymatic digestion were performed to determine the localization of bound HRGP.

Main Results:

• Specific, dose-dependent, and divalent cation-dependent binding of HRGP to activated human platelets was observed.
• Platelet activation with BDB-IgG, thrombin, or collagen significantly increased 125I-HRGP binding.
• Up to 16,000 HRGP molecules bound per platelet, but saturation was not reached.
• Platelet inhibitors markedly reduced HRGP binding capacity.
• Enzymatic digestion studies confirmed that bound HRGP remains on the platelet surface.

Conclusions:

• HRGP specifically binds to the surface of activated human platelets.
• This interaction is modulated by platelet activation state, divalent cations, and certain platelet inhibitors.
• The findings suggest a potential role for HRGP in platelet function or interactions within the vascular environment.